Renhuang Pharmaceuticals changes name to China Botanic Pharmaceutical

China Botanic Pharmaceutical Inc. (NYSE Amex: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that the Company's Articles of Incorporation have been amended to effect the name change of the Company from its former name of Renhuang Pharmaceuticals.

China Botanic noted that after four years it is retiring the name Renhuang Pharmaceuticals and will now officially be known as China Botanic Pharmaceutical Inc. to better reflect the Company's corporate identity, brand image and business operations. The legal structure of China Botanic remains unchanged.

"We are a rapidly growing and expanding botanic and bio-pharmaceutical company and we believe our new corporate name better reflects our business operations and product portfolio," said Mr. Shaoming Li, the Chairman and CEO of China Botanic Pharmaceutical Inc. "We believe our new name – China Botanic Pharmaceutical Inc. can be easily associated with our brand promise and our product categories, and will be well accepted in our target markets. We are actively expanding sales beyond our leading Siberian Ginseng products and introducing new products to drive future revenue and net income growth. We believe this is a good time to set the stage for our new corporate and brand entity."

Source:

China Botanic Pharmaceutical Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows how a single defective BRCA1 gene accelerates cancer development